Primate skin allotransplantation with anti-CD154 monotherapy

被引：14

作者：

Elster, EA

Xu, H

Tadaki, DK

Burkly, LC

Berning, JD

Baumgartner, RE

Cruzata, F

Patterson, NB

Harlan, DM

Kirk, AD

机构：

[1] NIDDK, Navy Transplantat & Autoimmun Branch, Bethesda, MD 20892 USA

[2] Natl Naval Med Ctr, Dept Gen Surg, Bethesda, MD USA

[3] Biogen Inc, Cambridge, MA 02142 USA

来源：

TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 1-2期

关键词：

D O I：

10.1016/S0041-1345(00)02197-7

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：675 / 676

页数：2

共 6 条

[1] Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged craft survival in a CTLA4-dependent manner [J].

Iwakoshi, NN ;

Mordes, JP ;

Markees, TG ;

Phillips, NE ;

Rossini, AA ;

Greiner, DL .

JOURNAL OF IMMUNOLOGY, 2000, 164 (01) :512-521

[2] Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154 [J].

Kenyon, NS ;

Chatzipetrou, M ;

Masetti, M ;

Ranuncoli, A ;

Oliveira, M ;

Wagner, JL ;

Kirk, AD ;

Harlan, DM ;

Burkly, LC ;

Ricordi, C .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (14) :8132-8137

[3] CTLA4-Ig and anti-CD4O ligand prevent renal allograft rejection in primates [J].

Kirk, AD ;

Harlan, DM ;

Armstrong, NN ;

Davis, TA ;

Dong, YC ;

Gray, GS ;

Hong, XN ;

Thomas, D ;

Fechner, JH ;

Knechtle, SJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (16) :8789-8794

[4] Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates [J].

Kirk, AD ;

Burkly, LC ;

Batty, DS ;

Baumgartner, RE ;

Berning, JD ;

Buchanan, K ;

Fechner, JH ;

Germond, RL ;

Kampen, RL ;

Patterson, NB ;

Swanson, SJ ;

Tadaki, DK ;

TenHoor, CN ;

White, L ;

Knechtle, SJ ;

Harlan, DM .

NATURE MEDICINE, 1999, 5 (06) :686-693

[5] Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways [J].

Larsen, CP ;

Elwood, ET ;

Alexander, DZ ;

Ritchie, SC ;

Hendrix, R ;

TuckerBurden, C ;

Cho, HR ;

Aruffo, A ;

Hollenbaugh, D ;

Linsley, PS ;

Winn, KJ ;

Pearson, TC .

NATURE, 1996, 381 (6581) :434-438

[6] Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4+ T cells, interferon-γ, and CTLA4 [J].

Markees, TG ;

Phillips, NE ;

Gordon, EJ ;

Noelle, RJ ;

Shultz, LD ;

Mordes, JP ;

Greiner, DL ;

Rossini, AA .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (11) :2446-2455

← 1 →